New study claims 'only children' are creative but more likely to be self-centred

Kids who grow up without siblings may be more creative, but are likely to be self-centred, say scientists who found significant differences in the brain structures of 'only children'.

IANS May 14, 2017 12:55:52 IST
New study claims 'only children' are creative but more likely to be self-centred
New study claims only children are creative but more likely to be selfcentred

Representational image. Getty images

Beijing: Kids who grow up without siblings may be more creative, but are likely to be self-centred, say scientists who found significant differences in the brain structures of 'only children'. Researchers in Southwest University in Chongqin in China studied about 250 college-aged students and identified significant differences in the brain regions associated with imagination, agreeableness and emotional regulation.

According to the researchers, the brain structure of only children reinforces "undesirable personality traits, such as dependency, selfishness and social ineptitude."

The "socialising effects" of having siblings, bestows upon most people "the realisation that they are not the centre of the world," the researchers said in the study published in the journal Brain Imaging and Behaviour. Researchers also noted that only children are more aware of parental expectations, which strongly influences their creativity, The Telegraph' reported. "Only children might have more opportunities for independent activity, and independence is strongly related to creative thinking," they said.

The findings may suggest that family environment plays an important role in the development of individuals behaviour and brain structure.

Updated Date:

also read

DCGI approves phase II/III trials of Covaxin on children between 2 to 18 years
India

DCGI approves phase II/III trials of Covaxin on children between 2 to 18 years

The Union Health Ministry said that the clinical trials will be conducted on 525 healthy volunteers from the age group

Pfizer/BioNTech seeks EU's approval to vaccinate children between ages 12-15 years
World

Pfizer/BioNTech seeks EU's approval to vaccinate children between ages 12-15 years

BioNTech CEO Ugur Sahin said ongoing trials are "very encouraging" and that "children are very well protected by the vaccine".

SEC recommends Bharat Biotech’s Covaxin phase 2, 3 clinical trials on 2- to 18-year-olds
India

SEC recommends Bharat Biotech’s Covaxin phase 2, 3 clinical trials on 2- to 18-year-olds

The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS Patna and Meditrina Institute of Medical Sciences, Nagpur.